Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Buspirone and Melatonin for Depression Following Traumatic Brain Injury

NCT04400266 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04400266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04400266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
August 1, 2020
Completion date
July 31, 2028
Enrollment
10 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain injuries, traumatic, depression